Br J Haematol 2023 Dec 10
Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.
Related Questions
Is there a role for nelarabine and venetoclax in this setting?
New answer by at University of Chicago (October 14, 2024)
Regimens to consider with data for R/R T-ALL include:
Nelarabine +/- chemotherapy. There are retrospective data to support adding nelarabine to a chemo backbone (Shimony et a...